Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation (original) (raw)

Mini-Review

Leukemia volume 11, pages 342–345 (1997)Cite this article

Abstract

The cell cycle has been the object of extensive studies for the past years. A complex network of molecular interactions has been identified. In particular, a class of cell cycle inhibitory proteins has been cloned and characterized but details of the molecular mechanism of their action have yet to be resolved. These inhibitors regulate the progression through G1 and the G1/S transition via the inhibition of the cyclin-dependent kinase (Cdk) activity. The potential function of these negative regulators as tumor suppressors provides new insights into the link between the cell cycle and oncogenesis. p27 is a potent inhibitor of Cdks. In quiescent cells p27 accumulates without an increase in mRNA or protein synthesis. Cell cycle regulation of p27 levels, both in normal and transformed human cells, occurs via the ubiquitin–proteasome pathway and, compared to proliferating cells, quiescent cells contain a far lower amount of p27 ubiquitinating activity. The specific proteolysis of p27 is probably involved in the pathway of activation of Cdks. p27 is a phosphoprotein and its phosphorylation is cell cycle regulated. Often phosphorylation is a signal for ubiquitination. p27 is phosphorylated exclusively on serine by Erk1 and almost exclusively on threonine by Cdk1 in in vitro experiments. This finding raises the question of whether and how phosphorylation by these kinases is involved in the process of p27 proteolysis.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Renal Unit, Massachusetts General Hospital East, Massachusetts, USA
    A Alessandrini
  2. Department of Pathology, Kaplan Comprehensive Cancer Center New York University Medical Center, New York, NY, USA
    DS Chiaur & M Pagano

Authors

  1. A Alessandrini
    You can also search for this author inPubMed Google Scholar
  2. DS Chiaur
    You can also search for this author inPubMed Google Scholar
  3. M Pagano
    You can also search for this author inPubMed Google Scholar

Rights and permissions

About this article

Cite this article

Alessandrini, A., Chiaur, D. & Pagano, M. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation.Leukemia 11, 342–345 (1997). https://doi.org/10.1038/sj.leu.2400581

Download citation

Keywords

This article is cited by